The Polyphenol Piceid Destabilizes Preformed Amyloid Fibrils and Oligomers in Vitro: Hypothesis on Possible Molecular Mechanisms

Neurochemical Research

Volumn 34, Issue 6, 2009, Pages 1120-1128

  Rivière, Céline ^a   Delaunay, Jean Claude ^a   Immel, Françoise ^b   Cullin, Christophe ^b   Monti, Jean Pierre ^a  

^a Bordeaux Segalen University   (France)

^b Institut de Biochimie et Genetique Cellulaires   (France)

Author keywords

Amyloid; Alzheimer's disease; Fibrils; Oligomers; Polyphenols

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; MONOMER; OLIGOMER; PICEID; POLYPHENOL; STILBENE DERIVATIVE;

ALZHEIMER DISEASE; ARTICLE; HYDROPHOBICITY; IN VITRO SELECTION; MOLECULAR MECHANICS; NEUROTOXICITY; OLIGOMERIZATION; PRIORITY JOURNAL;

AMYLOID; AMYLOID BETA-PROTEIN; CHROMATOGRAPHY, GEL; FLAVONOIDS; FLUORESCENT DYES; GLUCOSIDES; HUMANS; MICROSCOPY, ELECTRON; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; PHENOLS; PROTEIN STRUCTURE, SECONDARY; SPECTROMETRY, FLUORESCENCE; STILBENES; THIAZOLES;

EID: 64249166299     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-008-9883-6     Document Type: Article

References (70)

1. DJ Selkoe 1997 Alzheimer's disease: genotypes, phenotypes, and treatments Science 275 630 631 10.1126/science.275.5300.630
2. RM Murphy 2007 Kinetics of amyloid formation and membrane interaction with amyloidogenic proteins Biochim Biophys Acta 1768 1923 1934 10.1016/j.bbamem.2006.12.014 and references therein
3. TE Golde 2006 Disease modifying therapy for AD? J Neurochem 99 689 707 10.1111/j.1471-4159.2006.04211.x
4. JC Rochet PT Lansbury Jr 2000 Amyloid fibrillogenesis: themes and variations Curr Opin Struct Biol 10 60 68 10.1016/S0959-440X(99)00049-4 and references therein
5. A Monji H Utsumi T Ueda 2001 The relationship between the aggregational state of the amyloid-beta peptides and free radical generation by the peptides J Neurochem 77 1425 1432 10.1046/j.1471-4159.2001.00392.x
6. R Sultana S Newman H Mohmmad-Abdul 2004 Protective effect of the xanthate, D609, on Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress in primary neuronal cells Free Radic Res 38 449 458 10.1080/ 1071576042000206478
7. BJ Tabner OM El-Agnaf S Turnbull 2005 Hydrogen peroxide is generated during the very early stages of aggregation of the amyloid peptides implicated in Alzheimer disease and familial British dementia J Biol Chem 280 35789 35792 10.1074/jbc.C500238200
8. BL Kagan Y Hirakura R Azimov 2002 The channel hypothesis of Alzheimer's disease: current status Peptides 23 1311 1315 10.1016/S0196-9781(02)00067-0
9. CM Lauderback J Kanski JM Hackett 2002 Apolipoprotein E modulates Alzheimer's Abeta(1-42)-induced oxidative damage to synaptosomes in an allele-specific manner Brain Res 924 90 97 10.1016/S0006-8993(01)03228-0
10. UC Oppermann S Salim LO Tjernberg 1999 Binding of amyloid beta-peptide to mitochondrial hydroxyacyl-CoA dehydrogenase (ERAB): regulation of an SDR enzyme activity with implications for apoptosis in Alzheimer's disease FEBS Lett 451 238 242 10.1016/S0014-5793(99)00586-4
11. DM Holtzman 2004 In vivo effects of ApoE and clusterin on amyloid-beta metabolism and neuropathology J Mol Neurosci 23 247 254 10.1385/JMN:23:3:247
12. M Sadowski J Pankiewicz H Scholtzova 2004 A synthetic peptide blocking the apolipoprotein E/beta-amyloid binding mitigates beta-amyloid toxicity and fibril formation in vitro and reduces beta-amyloid plaques in transgenic mice Am J Pathol 165 937 948
13. JW Lustbader M Cirilli C Lin 2004 ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease Science 304 448 452 10.1126/science.1091230
14. DJ Selkoe 1999 Translating cell biology into therapeutic advances in Alzheimer's disease Nature 399 A23 A31 10.1038/19866
15. BA Yankner 1996 Mechanisms of neuronal degeneration in Alzheimer's disease Neuron 16 921 932 10.1016/S0896-6273(00)80115-4
16. CJ Pike AJ Walencewicz CG Glabe 1991 In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity Brain Res 563 311 314 10.1016/0006-8993(91)91553-D
17. CJ Pike D Burdick AJ Walencewicz 1993 Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state J Neurosci 13 1676 1687
18. A Lorenzo BA Yankner 1994 Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red Proc Natl Acad Sci USA 91 12243 12247 10.1073/pnas.91.25.12243
19. DJ Selkoe 2004 Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases Nat Cell Biol 6 1054 1061 10.1038/ncb1104-1054
20. MP Lambert AK Barlow BA Chromy 1998 Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins Proc Natl Acad Sci USA 95 6448 6453 10.1073/pnas.95.11.6448
21. DM Walsh DM Hartley Y Kusumoto 1999 Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates J Biol Chem 274 25945 25952 10.1074/jbc.274.36.25945
22. R Bhatia H Lin R Lal 2000 Fresh and globular amyloid beta protein (1-42) induces rapid cellular degeneration: evidence for AbetaP channel-mediated cellular toxicity FASEB J 14 1233 1243
23. YJ Zhu H Lin R Lal 2000 Fresh and nonfibrillar amyloid beta protein(1-40) induces rapid cellular degeneration in aged human fibroblasts: evidence for AbetaP-channel-mediated cellular toxicity FASEB J 14 1244 1254
24. WL Klein GA Krafft CE Finch 2001 Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum? Trends Neurosci 24 219 224 10.1016/S0166-2236(00)01749-5
25. HJ Kim SC Chae DK Lee 2003 Selective neuronal degeneration induced by soluble oligomeric amyloid beta protein FASEB J 17 118 120
26. J Hardy DJ Selkoe 2002 The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297 353 356 10.1126/science.1072994 Erratum in: Science. 2002. 297:2209 and comment in: Science. 2002 298:962-964
27. R Kayed E Head JL Thompson 2003 Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis Science 300 486 489 10.1126/science.1079469
28. K Ono Y Yoshiike A Taskashima 2003 Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease J Neurochem 87 172 181 10.1046/j.1471-4159.2003.01976.x
29. K Ono K Hasegawa H Naiki 2004 Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro J Neurosci Res 75 742 750 10.1002/jnr.20025
30. K Ono K Hasegawa H Naiki 2004 Anti-amyloidogenic activity of tannic acid and its activity to destabilize Alzheimer's beta-amyloid fibrils in vitro Biochim Biophys Acta 1690 193 202
31. C Rivière T Richard L Quentin 2007 Inhibitory activity of stilbenes on Alzheimer's beta-amyloid fibrils in vitro Bioorg Med Chem 15 1160 1167 10.1016/j.bmc.2006.09.069
32. C Rivière T Richard X Vitrac 2008 New polyphenols active on beta-amyloid aggregation Bioorg Med Chem Lett 18 828 831 10.1016/j.bmcl.2007.11. 028
33. F Yang GP Lim AN Begum 2005 Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo J Biol Chem 280 5892 5901 10.1074/jbc.M404751200
34. S Bastianetto ZX Yao V Papadopoulos 2006 Neuroprotective effects of green and black teas and their catechin gallate esters against beta-amyloid-induced toxicity Eur J NeuroSci 23 55 64 10.1111/j.1460-9568.2005.04532.x
35. GP Hubbard S Wolffram JA Lovegrove 2003 The role of polyphenolic compounds in the diet as inhibitors of platelet function Proc Nutr Soc 62 469 478 10.1079/PNS2003253
36. A Scalbert C Manach C Morand 2005 Dietary polyphenols and the prevention of diseases Crit Rev Food Sci Nutr 45 287 306 10.1080/1040869059096
37. CS Yang S Prabhu J Landau 2001 Prevention of carcinogenesis by tea polyphenols Drug Metab Rev 33 237 253 10.1081/DMR-120000651
38. C Manach A Scalbert C Morand 2004 Polyphenols: food sources and bioavailability Am J Clin Nutr 79 727 747
39. Rossi L, Mazzitelli S, Arciello M et al. (2008) Benefits from dietary polyphenols for brain aging and Alzheimer's disease. Neurochem Res (Published online)
40. T Richard S Verge B Berke 2001 NMR and simulated annealing investigations of bradykinin in presence of polyphenols J Biomol Struct Dyn 18 627 637
41. AJ Charlton NJ Baxter ML Khan 2002 Polyphenol/peptide binding and precipitation J Agric Food Chem 50 1593 1601 10.1021/jf010897z
42. AJ Charlton E Haslam MP Williamson 2002 Multiple conformations of the proline-rich protein/epigallocatechin gallate complex determined by time-averaged nuclear Overhauser effects J Am Chem Soc 124 9899 9905 10.1021/ja0126374
43. S Vergé T Richard S Moreau 2002 First observation of solution structures of bradykinin-penta-O-galloyl-d-glucopyranose complexes as determined by NMR and simulated annealing Biochim Biophys Acta 1571 89 101
44. T Richard X Vitrac JM Merillon 2005 Role of peptide primary sequence in polyphenol-protein recognition: an example with neurotensin Biochim Biophys Acta 1726 238 243
45. NJ Murray MP Williamson TH Lilley 1994 Study of the interaction between salivary proline-rich proteins and a polyphenol by 1H-NMR spectroscopy Eur J Biochem 219 923 935 10.1111/j.1432-1033.1994.tb18574.x
46. E Haslam 1974 Polyphenol-protein interactions Biochem J 139 285 288
47. T Richard JC Delaunay JM Merillon 2003 Is the C-terminal region of bradykinin the binding site of polyphenols? J Biomol Struct Dyn 21 379 385
48. C Simon K Barathieu M Laguerre 2003 Three-dimensional structure and dynamics of wine tannin-saliva protein complexes a multitechnique approach Biochemistry 42 10385 10395 10.1021/bi034354p
49. A Klegeris DG Walker PL [tmp] McGeer 1994 Activation of macrophages by Alzheimer beta amyloid peptide Biochem Biophys Res Commun 199 984 991 10.1006/bbrc.1994.1326
50. CJ Pike AJ Walencewicz-Wasserman J Kosmoski 1995 Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity J Neurochem 64 253 265
51. E Hughes RM Burke AJ Doig 2000 Inhibition of toxicity in the beta-amyloid peptide fragment beta-(25-35) using N-methylated derivatives: a general strategy to prevent amyloid formation J Biol Chem 275 25109 25115 10.1074/jbc.M003554200
52. H Naiki K Higuchi M Hosokawa 1989 Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye thioflavine T Anal Biochem 177 244 249 10.1016/0003-2697(89)90046-8
53. BA Chromy RJ Nowak MP Lambert 2003 Self-assembly of Abeta (1-42) into globular neurotoxins Biochemistry 42 12749 12760 10.1021/bi030029q
54. H Atamna K Boyle 2006 Amyloid-beta peptide binds with heme to form a peroxidase: relationship to the cytopathologies of Alzheimer's disease Proc Natl Acad Sci USA 103 3381 3386 10.1073/pnas.0600134103
55. DM Walsh A Lomakin GB Benedek 1997 Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate J Biol Chem 272 22364 22372 10.1074/jbc.272.35.22364
56. S Chimon MA Shaibat CR Jones 2007 Evidence of fibril-like beta-sheet structures in a neurotoxic amyloid intermediate of Alzheimer's beta-amyloid Nat Struct Mol Biol 14 1157 1164 10.1038/nsmb1345
57. MM Pallitto RM Murphy 2001 A mathematical model of the kinetics of beta-amyloid fibril growth from the denatured state Biophys J 81 1805 1822
58. K Hasegawa K Ono M Yamada 2002 Kinetic modeling and determination of reaction constants of Alzheimer's beta-amyloid fibril extension and dissociation using surface plasmon resonance Biochemistry 41 13489 13498 10.1021/bi020369w
59. K Ono M Hirohata M Yamada 2005 Ferulic acid destabilizes preformed beta-amyloid fibrils in vitro Biochem Biophys Res Commun 336 444 449 10.1016/j.bbrc.2005.08.148
60. AT Petkova Y Ishii JJ Balbach 2002 A structural model for Alzheimer's beta-amyloid fibrils based on experimental constraints from solid state NMR Proc Natl Acad Sci USA 99 16742 16747 10.1073/pnas.262663499
61. AT Petkova WM Yau R Tycko 2006 Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils Biochemistry 45 498 512 10.1021/bi051952q
62. T Lührs C Ritter M Adrian 2005 3D structure of Alzheimer's amyloid-beta(1-42) fibrils Proc Natl Acad Sci USA 102 17342 17347 10.1073/pnas.0506723102
63. E Terzi G Hölzemann J Seelig 1994 Alzheimer beta-amyloid peptide 25-35: electrostatic interactions with phospholipid membranes Biochemistry 33 7434 7441 10.1021/bi00189a051
64. T Konno 2001 Amyloid-induced aggregation and precipitation of soluble proteins: an electrostatic contribution of the Alzheimer's beta (25-35) amyloid fibril Biochemistry 40 2148 2154 10.1021/bi002156h
65. JH Ippel A Olofsson J Schleucher 2002 Probing solvent accessibility of amyloid fibrils by solution NMR spectroscopy Proc Natl Acad Sci USA 99 8648 8653 10.1073/pnas.132098999
66. MS Kellermayer L Grama A Karsai 2005 Reversible mechanical unzipping of amyloid beta-fibrils J Biol Chem 280 8464 8470 10.1074/jbc.M411556200
67. H Zeng Y Zhang L Peng 2001 Nicotine and amyloid formation Biol Psychiatry 49 248 257 10.1016/S0006-3223(00)01111-2
68. R Liu C [tmp] McAllister Y Lyubchenko 2004 Residues 17-20 and 30-35 of beta-amyloid play critical roles in aggregation J Neurosci Res 75 162 171 10.1002/jnr.10859
69. AP Pawar KF Dubay J Zurdo 2005 Prediction of "aggregation- prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases J Mol Biol 350 379 392 10.1016/j.jmb.2005.04.016
70. G Wei JE Shea 2006 Effects of solvent on the structure of the Alzheimer amyloid-beta(25-35) peptide Biophys J 91 1638 1647 10.1529/biophysj.105.079186 and references therein